Xarelto gets EU nod
March 25, 2013Sales and Marketing Bayer, Xarelto
Bayer HealthCare has been given a boost by the recommendation in Europe of its oral blood thinner Xarelto to prevent …
LEO Pharma appoints two divisional directors
March 25, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing LEO Pharma
LEO Pharma has made two new appointments to the leadership team of its UK/Ireland affiliate.Mike Williams (pictured) joins to head …
AstraZeneca hires strategy boss
March 25, 2013Sales and Marketing AstraZeneca, dunoyer
AstraZeneca has poached one of GlaxoSmithKline’s senior executives to help push through its new growth strategy. Marc Dunoyer, global head …
Actavis to invest in Florida facility
March 25, 2013Manufacturing and Production Actavis, Watson
Actavis has announced a $40.5 million investment round at its plant in Davie, Florida, that looks set to create around …
Two Apotex facilities cited by FDA
March 25, 2013Manufacturing and Production Apotex, FDA
Canadian generic drugmaker Apotex has been sent another warning letter by the FDA after violations were uncovered at two manufacturing …
Contract research news in brief
March 22, 2013Research and Development Calvert labs, Frontage Labs, Medrio, Mytrus, Particle Sciences, Sotio, chiltern, inVentiv Health
inVentiv takes stake in Mytrus, Frontage Labs FDA-inspected, plus updates from Chiltern, Calvert Labs/Particle Sciences and Medrio.
Pharma manufacturing news in brief
March 22, 2013Manufacturing and Production APIC, Agila, Avitide, Catalent, Contego, Malaysian Bio-XCell, Nueland Labs, ShangPharma, Zhejiang biotech
Agila to build a new facility in Malaysia, Avitide raises money for new bioprocessing technology, plus alliance and acquisition news …
Merck KGaA/BMS China deal
March 22, 2013Sales and Marketing BMS, Merck KGaA, diabetes
Merck KGaA and Bristol-Myers Squibb are to co-promote the German firm’s veteran diabetes drug Glucophage in different formations in China. …
Two new appointments at PAN
March 22, 2013Medical Communications, Sales and Marketing Pan, advertising
Creative agency PAN has welcomed two new team members in senior copywriter Sarah White and account manager Rachel Flavell. White …
NICE to assess drug value
March 22, 2013Sales and Marketing EMIG, NHS, NICE, VBP
NICE will be responsible for assessing the full value of medicines – taking into account their benefit to patients and …
AstraZeneca sets out growth strategy
March 21, 2013Sales and Marketing AstraZeneca, R&D
AstraZeneca has set out an ambitious plan designed to return it to growth which eschews diversification and sets great store …
Budget 2013: pharma ‘pleased’
March 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Budget, Osborne, UK
Pharma and health bodies have broadly given George Osborne’s Budget a warm welcome, with cuts in corporation tax, increased R&D …
Targacept makes changes to Board and management
March 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targacept
Clinical-stage biopharma firm Targacept has announced several changes to its Board of directors and management. By the end of May …
Underwhelming results for Victoza
March 20, 2013Sales and Marketing Novo Nordisk, Victoza, diabetes
Novo Nordisk has reported underwhelming results for a well-established diabetes treatment in a late-stage trial designed to test its weight …
MPs: NHS must be ‘re-imagined’
March 20, 2013Sales and Marketing Dorrell, NHS
Increasing cost pressure on the NHS will lead to a breakdown in health and social care services unless commissioning becomes …
Ziarco appoints John LaMattina as R&D advisor
March 20, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing LaMattina, Ziarco
Ex-global head of Pfizer R&D and Pharmafocus regular John LaMattina has been given a strategic advisory role by biotech firm …
Knee trial for Merck KGaA
March 19, 2013Research and Development, Sales and Marketing Merck KGaA, knee, nordic
Merck KGaA is to begin a Phase IIb trial of its investigational drug sprifermin in patients with osteoarthritis (OA) of …
AstraZeneca restructures global R&D
March 19, 2013Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, R&D
AstraZeneca is restructuring its global operations in a bid to improve the productivity of its R&D operations. The firm is …
New associate director for PAN
March 19, 2013Medical Communications, Sales and Marketing Pan
Creative comms agency PAN has announced that Sarah Verhoeff has joined the firm from Havas Life as an associate director.Verhoeff …
ECHA examines safety of cobalt salts used in pharma manufacturing
March 19, 2013Manufacturing and Production ECHA, cobalt
The European Chemicals Agency (ECHA) is looking into the safety of five cobalt salts that have applications in pharmaceutical manufacturing. …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
